Neural Injury and Functional Reconstruction.
Accepted: 2025-09-29
To systematically evaluate the impact of virtual reality (VR) technology on cognitive
function in stroke patients. Methods: A computer-based search was conducted across multiple domestic and
international databases for randomized controlled trials (RCTs) investigating VR interventions in patients with
post-stroke cognitive impairment. The search period spanned from the inception of the databases to January 7,
2025. The Cochrane Collaboration's Risk of Bias tool and the Physiotherapy Evidence Database (PEDro) scale
were employed to assess the quality of the included studies. Data analysis was performed using RevMan 5.4.1
software. Results: A total of 14 studies, involving 723 patients, were ultimately included. All included studies
were of high quality, with PEDro scale scores ranging from 6 to 10. Meta-analysis results indicated that VR
technology significantly improved the Montreal Cognitive Assessment (MoCA) score [MD=2.53, 95% CI (0.82,
4.24), P=0.004], the Mini-Mental State Examination (MMSE) score [MD=1.68, 95% CI (1.12, 2.24), P<0.00001],
the P300 latency [MD=-25.48, 95% CI (-38.99, -11.96), P=0.0002], the P300 amplitude [MD=0.72, 95% CI
(0.14, 1.30), P=0.02], and the Barthel Index or Modified Barthel Index (BI or MBI) score [MD=5.14, 95% CI
(3.25, 7.03), P<0.00001] in stroke patients with cognitive impairment. However, no significant effects were
observed on the Trail Making Test Part A (TMT-A) score [MD=-12.47, 95% CI (-27.16, 2.23), P=0.10] or the
TMT-B score [MD=- 44.35, 95% CI (- 117.45, 28.74), P=0.23]. Conclusion: VR technology can improve
cognitive function and activities of daily living (ADL) abilities in stroke patients.